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Abstract Ca2+ signaling plays an important role in the function
of dendritic cells (DC), the specialized antigen-presenting cells of
the immune system. Here we describe functional ryanodine
receptor (RyR) Ca2+ release channels in murine, bone marrow-
derived DC. RT-PCR analysis identified selective expression of
the type 1 RyR, with higher levels detected in immature rather
than mature DC. The RyR activators caffeine, FK506, ryanodine
and 4-chloro-m-cresol mobilized Ca2+ in DC, and responses to
4-chloro-m-cresol were inhibited by dantrolene. Furthermore,
activation of RyRs both inhibited subsequent inositol trisphos-
phate-mediated Ca2+ release and provoked store-operated Ca2+
entry, suggesting a functional interaction between these intra-
cellular Ca2+ channels. Thus, the RyR1 channel may play an
intrinsic role in Ca2+ signaling in DC. ß 2002 Federation of
European Microbiological Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
The ryanodine receptor (RyR) is a major intracellular Ca2
release channel found in many cell types. Although the best-
known function of RyRs is to provide the Ca2 trigger for
muscle contraction the channels may also play important roles
in diverse cell signaling pathways [1^3]. Three types of RyR
(RyR1^3) have been described; each is the product of a di¡er-
ent gene. RyR1 and RyR2 are expressed predominantly in
skeletal muscle and heart respectively, although low-level ex-
pression is found in a number of tissues. RyR3, in contrast, is
widely expressed, including neurons and leukocytes. The role
of RyRs in ‘non-excitable’ lymphoid tissue is not well under-
stood, but RyRs in these cells may serve to amplify Ca2 rises
initiated by inositol trisphosphate receptors (IP3Rs). Indeed,
in T cells, RyR3 may contribute to the sustained Ca2 rise
that is necessary for T cell proliferation [4,5]. Here we report
the expression of the ‘skeletal muscle’ RyR1 channel in den-
dritic cells (DC), rare leukocytes highly specialized for the
induction of primary immune responses. Immature DC,
present in virtually all tissues and organs, possess a high ca-
pacity for the uptake and processing of antigen. After encoun-
tering antigen these DC migrate to secondary lymphoid tis-
sues where they e⁄ciently stimulate naive antigen-speci¢c T
cells [6,7]. Although Ca2 signaling pathways are thought to
regulate DC activity [8^10], these pathways have not been well
characterized. Here we show that DC express functional
RyR1 channels. In addition, we demonstrate that RyR ex-
pression is developmentally regulated and that RyRs may
functionally interact with the IP3R Ca2 stores. These results
suggest that RyR1 channels are fundamentally involved in
DC Ca2 signaling and support a broader role for the
RyR1 channel outside skeletal muscle.
2. Materials and methods
2.1. DC culture and puri¢cation
DC were cultured from bone marrow cells isolated from the femurs
and tibias of normal C57BL/10J mice (6^12 weeks old) using granu-
locyte/macrophage colony-stimulating factor (GM-CSF) and interleu-
kin (IL) 4 (4 ng/ml and 1000 U/ml respectively) as previously de-
scribed [11]. The culture medium, RPMI 1640 (Life Technologies,
Rockville, MD, USA), was supplemented with 10% fetal calf serum
(Nalgene, Miami, FL, USA), non-essential amino acids, L-glutamine,
sodium pyruvate, penicillin^streptomycin and 2-ME (all from Life
Technologies). DC were harvested after 5 days of culture and puri¢ed
by density (145 mg/ml metrizamide; Sigma) centrifugation. For anal-
ysis of RyR transcript expression by immature and mature DC, bone
marrow cultures were enriched for DC by density centrifugation
(165 mg/ml metrizamide) and stained with anti-CD11c and anti-
CD86 conjugated to £uorescein isothiocyanate and phycoerythrin re-
spectively (BD Biosciences, San Diego, CA, USA). CD11c CD863
(immature) and CD11c CD86 (mature) cells with high forward and
side scatter pro¢les were separated and puri¢ed to v 95% purity using
a Beckman Coulter EPICS Elite (Hialeah, FL, USA).
2.2. RT-PCR
Total cellular RNA was extracted using TRIzol (Life Technologies,
Rockville, MD, USA) according to the manufacturer’s instructions.
First strand cDNA was synthesized using Advantage RT-for-PCR
(Clontech Laboratories, Palo Alto, CA, USA) with the supplied
oligo(dT)16 primer. 50^100 ng of cDNA was used for each subsequent
PCR. Relatively equal quantities of cDNA were ensured by amplify-
ing a 540 bp segment of L-actin [12] using a Gene Amp0 PCR System
2400 (Perkin Elmer, Norwalk, CT, USA). RyR expression was de-
tected by ampli¢cation of a 1.2 kb fragment common to RyR1^3
transcripts [4]. RyR subtype expression was determined by amplifying
fragments speci¢c for RyR1 (298 bp), RyR2 (1179 bp) and RyR3 (537
bp) transcripts using subtype-speci¢c primers [13]. Transcripts were
ampli¢ed by 35 or 40 cycles (RyR1^3 subtypes or pan-RyR, respec-
tively) of 20 s 95‡C, 30 s 55‡C and 30 s 72‡C followed by a ¢nal
extension step of 5 min at 72‡C. RT-PCR products were separated by
agarose gel electrophoresis and visualized with ethidium bromide £uo-
rescence.
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2.3. Fluorescence measurements
DC were plated on coverslips in culture media and loaded with
Fluo-3AM (3^5 WM) for 20 min at 25‡C. Cells were then washed
with several volumes of bathing solution and left for a further
20 min prior to recording. Standard bathing solution was (in mM)
130 NaCl, 4 KCl, 10 HEPES, 10 glucose, 2 CaCl2, 1 MgCl2, pH 7.3.
Drugs were applied via a pu¡er pipette placed near the cell. Fluores-
cence measurements were made using a Deltascan £uorometer (Pho-
ton Technology International, South Brunswick, NJ, USA) coupled to
a Diastar microscope (Reichert Jung) or a Fluoview confocal micro-
scope. Fluo-3 was excited at 488 nm and emitted £uorescence was
¢ltered with a 535 þ 25 nm bandpass ¢lter.
All values are expressed as mean þ S.E.M. Statistical di¡erences
were evaluated using Student’s t-test. Recombinant (r) GM-CSF
and IL-4 were gifts of Dr. S.K. Narula (Schering-Plough, Kenilworth,
NJ, USA). FK506 was a gift from Fujisawa. Ryanodine was obtained
from Calbiochem. All other drugs/reagents were from Sigma.
3. Results
3.1. RyR ligands induce intracellular Ca2+ rises in
dendritic cells
We tested for the presence of functional RyRs in mature
DC (CD11c, CD86) using Ca2 imaging techniques. Fig. 1
shows intracellular Ca2 changes (assessed as changes in
Fluo-3 £uorescence) in individual cells in response to well-
known RyR ligands. One second pulses of ca¡eine (10 mM)
produced rapid and reproducible Ca2 rises (5/6 cells). Rya-
nodine, the de¢nitive RyR modulator [14], induced either a
slow Ca2 transient (50^500 WM, 16/20 cells), or a more grad-
ual Ca2 rise (50 WM, 6/6 cells, data not shown). The immu-
nosuppressant, FK506 (25 WM), induced a slow irreversible
Ca2 rise in all cells tested (n = 5). This action of FK506 is
consistent with its ability to activate RyRs by dissociating the
tightly bound FK506 binding proteins from the channel com-
plex [15,16]. The RyR activator, 4-chloro-m-cresol (300 WM)
[17,18], evoked a large Ca2 rise (n = 20), and this e¡ect was
prevented by pretreatment with the RyR antagonist dantro-
lene [19,20] (25 WM, n = 10, data not shown). These results
provide clear pharmacological evidence for expression of
functional RyR channels in DC.
3.2. Identi¢cation of RyR1 in DC by RT-PCR analysis
The expression of RyR gene transcripts was con¢rmed in
DC by amplifying a 1.2 kb sequence common to all RyR
subtypes [4] by RT-PCR (Fig. 2A). Relatively high levels of
RyR transcripts were identi¢ed in both skeletal muscle and
immature DC. In contrast, RyR transcripts were barely de-
tectable in mature DC. To identify the RyR, transcripts spe-
ci¢c to each RyR subtype were ampli¢ed using subtype-spe-
ci¢c primers [13]. cDNA samples from skeletal muscle, heart,
and brain tissue were ampli¢ed in parallel with DC cDNA
samples as controls for RyR1, RyR2 and RyR3 respectively.
Fig. 1. RyR ligands evoke intracellular Ca2 increases in mature
DC. Individual Fluo-3-loaded DC were challenged with the drug-
containing solution, applied via a picospritzer pipette. A: One sec-
ond applications of 10 mM ca¡eine evoked repetitive Ca2 in-
creases. B: 25 WM FK506 produced a slow irreversible Ca2 rise.
C: 50 WM ryanodine produced a slow Ca2 transient.
Fig. 2. Identi¢cation of RyR1 in DC by RT-PCR. A: Detection of
RyR expression in skeletal muscle, immature and mature DC
cDNA samples by ampli¢cation of a sequence common to all three
RyRs. B: RT-PCR of sequences speci¢c for each of the three RyRs
(RyR1^3) demonstrates that RyR1 is the predominant subtype ex-
pressed in both immature and mature DC. Skeletal muscle, heart,
and brain samples were used as positive controls for RyR1^3 ex-
pression respectively. Note that a band corresponding to RyR2
from heart cDNA was clearly seen in the original photograph but is
not clear in the reproduction. Ampli¢cation of L-actin was used as
an internal positive control in all experiments.
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Fig. 2B shows that only RyR1 transcripts were detected in
two samples of both immature and mature DC cDNA.
Thus, DC express the type 1 or skeletal muscle RyR, but little
or no RyR2 or RyR3. Interestingly, expression of RyR1 tran-
scripts was greater in immature compared with mature DC,
consistent with the results found using the pan-RyR primer
set (Fig. 2A).
3.3. RyRs are functionally coupled to IP3R Ca2
+ stores
We next considered whether RyRs might interact with the
IP3 signaling pathway in DC. IP3 is a key regulator of [Ca2]i
in leukocytes [21] ; and IP3-mediated Ca2 rises in DC accom-
pany chemokine and cytokine stimulation. RyRs, in turn, are
activated by increases in [Ca2]i (a process termed Ca2-in-
duced Ca2 release). Thus, the initial Ca2 rise triggered by
IP3 could activate RyRs in DC. Such a mechanism would be
enhanced if RyRs and IP3Rs were in close proximity.
Although IP3Rs and RyRs are traditionally thought to utilize
separate Ca2 stores there is evidence that these channels may
share Ca2 stores in Purkinje neurons [22]. We tested this
hypothesis in DC by examining whether activation of RyRs
and depletion of the RyR-speci¢c Ca2 store a¡ected subse-
quent IP3-mediated Ca2 release. DC were stimulated with 20
WM ATP to evoke IP3-mediated Ca2 responses as described
previously [10,23]. Fig. 3 shows representative ATP-evoked
Ca2 transients in individual DC either under control condi-
tions or after treatment with 50 WM ryanodine (10 min). The
Ca2 rise in the ryanodine-treated cells was signi¢cantly small-
er (P6 0.05, n = 4). This decrease was unlikely due to inhibi-
tion of RyRs by ryanodine; Ca2 rises could still be evoked
by other RyR ligands after ryanodine treatment, suggesting
that RyR channels were not blocked (data not shown). Thus,
the depression of the ATP-evoked response by ryanodine is
likely due to depletion of the IP3R-coupled Ca2 store. This
suggests that RyRs and IP3Rs in DC are both expressed in the
same membrane with a contiguous Ca2 store. To test this
possibility further, we investigated whether RyR activation
could lead to activation of store-operated Ca2 entry. We
have previously shown in DC that depletion of IP3R-coupled
Ca2 stores by thapsigargin, IP3, or ATP induces activation of
the store-operated current, ICRAC [10]. Therefore, we predicted
that depletion of the same store by RyR agonists would also
activate ICRAC. In Ca2 imaging experiments DC were treated
with ca¡eine in zero Ca2 medium. Upon readdition of a
Ca2-containing solution, a large Ca2 rise was observed con-
sistent with activation of store-operated channels (data not
shown). Thus, in DC both RyRs and IP3Rs appear to be
functionally coupled to ICRAC.
4. Discussion
Our results demonstrate clear evidence for RyR channels in
DC. Robust Ca2 rises were observed in response to a number
of characteristic RyR ligands. RT-PCR analysis con¢rmed
speci¢c expression of the RyR1 subtype. This result is consis-
tent with the intracellular Ca2 responses. FK506 has more
potent e¡ects on RyR1 than the other RyR subtypes [24,25],
while dantrolene inhibits RyR1 and RyR3 channels but has
no e¡ect on RyR2 [20]. The RyR1 subtype has been tradi-
tionally considered a ‘skeletal muscle’ channel and is essential
for triggering muscle contraction [2]. Thus, it is somewhat
surprising to ¢nd it expressed in DC. RyR1 expression has
been reported in B lymphocytes [26,27]. However, the role of
this RyR in B cells is unclear; the functional responses are not
as marked as we show here in DC. In particular, ca¡eine and
ryanodine fail to elicit Ca2 increases in B cells. In contrast,
the RyR3 channel expressed in T cells is activated by cyclic
ADP ribose and is believed to play an important role in anti-
gen-stimulated T cell proliferation [5]. DC, in turn, are potent
antigen-presenting cells, and the only leukocytes capable of
e⁄ciently activating naive T cells. Thus, these data support
a role for speci¢c RyR subtypes in di¡erent arms of the adap-
tive immune system.
Interestingly RT-PCR showed that RyR (which is predom-
Fig. 3. Ryanodine reduces IP3R-mediated Ca2 transients. A: Representative IP3R-mediated Ca2 transients evoked by ATP (30 WM) before
and 10 min after treatment with ryanodine (50 WM). Each trace is from a di¡erent cell. B: Mean þ S.E.M. response of control and ryanodine-
treated groups (n = 4 for both, P6 0.05).
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inantly RyR1) expression declined during DC maturation.
Although inducible RyR expression has been reported in
many tissues, for example, transforming growth factor-L in-
creases RyR1 and RyR3 mRNA levels in HeLa cells [28], the
down-regulation of RyR1 expression is less common. The
predominant expression of RyR1 in immature DC may indi-
cate a speci¢c functional role for this channel in DC matura-
tion or migration. However, the signi¢cance of this is unclear
as following activation, migration to secondary lymphoid tis-
sue and terminal maturation, DC are lost within 24^48 h [29]
presumably via programmed cell death [30,31]. Therefore, it is
possible that down-regulation of RyR1 mRNA is merely an
early manifestation of cell function shutdown prior to apopto-
sis. Note that functional RyR responses were seen in mature
DC (Fig. 1), indicating that RyR protein was still present in
these cells. This presumably re£ects a slow turnover rate of
the channels. Future experiments detailing RyR1 protein ex-
pression in DC cultured with survival factors, such as CD40L,
should resolve these issues.
Our data suggest that IP3Rs and RyRs in DC share the
same intracellular Ca2 store. These results suggest a func-
tional interplay between IP3Rs and RyRs during DC Ca2
signaling. A similar functional colocalization of these channels
has been proposed for Purkinje neurons [22,32]. Many of the
chemokines and growth factors that control DC maturation
and migration act via G protein-coupled receptors and initiate
IP3-mediated Ca2 rises [33^36]. Thus, RyRs coupled to IP3R
Ca2 stores may also participate in these important signaling
processes. These RyRs may serve to amplify an IP3-mediated
Ca2 spike. Moreover, colocalization of the channels may
enhance RyR activation. In muscle, the Ca2 threshold for
RyR activation is V100 nM and maximal activation is seen
at V10^100 WM [1]. The bulk [Ca2]i in DC during stimula-
tion may never exceed V1 WM [10,23], however the [Ca2]
near IP3R release sites would be much higher. Thus, RyRs
may be more e¡ectively activated situated close to IP3Rs.
Activation of RyRs and depletion of the Ca2 store will en-
hance the activation of the store-operated current, ICRAC. In
turn, the sustained Ca2 rise mediated by ICRAC can accelerate
DC maturation [10].
In summary, we show that DC express functional type 1
RyRs and propose that these channels may play a develop-
mental-speci¢c role in DC biology.
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